Latest news
Loading news…
CytoSolv
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down. Tiverton, Rhode Island, United States Founded 2009 11-50 employees For Profit
CytoSolv develops technology for the treatment of diabetic ulcers and other wounds.
CytoSolv was acquired by Semma Therapeutics in 2015.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 8
Company Info
- Founded
- 2009
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- HQ
- Tiverton, Rhode Island, United States
- Region
- East Coast, New England, Northeastern US
- Exit date
- Nov 16, 2015
- Closed
- Oct 1, 2009
Signals & Scores
- Trend (7d)
- -0.1
- Trend (30d)
- -0.4
- Trend (90d)
- -0.6
Key People at CytoSolv
Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to CytoSolv
Loading news…
FAQs about CytoSolv
People who checked this page also checked these
Browse the full Acquirezy directory.